MOXYDAR, oral suspension in a sachet 16 sachets of 20 ml
Active ingredients: Aluminum hydroxide, GOMME GUAR, Magnesium hydroxide, Aluminium phosphate
Commercialized according to BDPM
Oral suspension16 sachets of 20 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MOXYDAR, suspension buvable en sachet
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 16 sachet(s) polyester aluminium polyéthylène de 20 ml
- Marketing authorisation holder
- GRIMBERG
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 May 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63798152CIP73027763CIP133400930277638Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALUMINIUM (OXYDE D') HYDRATÉsuspension | 500 mg · un sachet de 20 ml | SA |
| GOMME GUARsuspension | 198,2 mg · un sachet de 20 ml | SA |
| HYDROXYDE DE MAGNÉSIUMsuspension | 500 mg · un sachet de 20 ml | SA |
| PHOSPHATE D'ALUMINIUMsuspension | 300 mg · un sachet de 20 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.